跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLONASE ALLERGY RELIEF - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FLONASE ALLERGY RELIEF
Authorized
STANDARD
FLONASE ALLERGY RELIEF
haleon canada ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4f1754f647a7ac7f
Company
haleon canada ulc
Type
Standard
Approval Details
Approval Id
4f1754f647a7ac7f
Drug Approval Canada Name
FLONASE ALLERGY RELIEF
Product Name
FLONASE ALLERGY RELIEF
Status
Marketed
Status Date
2024-07-24
Original Market Date
2017-02-01
Din
02248307
Drug Class
Human
Dosage Form
Spray, Metered Dose
Route Of Administration
Nasal
Schedule
OTC
Ahfs
52:08.00
Atc Original
R01AD08 FLUTICASONE
Atc Name
r 01 ad 08
Aig Number
0124685001
Company Name
haleon canada ulc
Company Address
450-55 Standish Court, Mississauga, Ontario, Canada, L5R 4B2
Active Ingredients
FLUTICASONE PROPIONATE
50 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4f1754f647a7ac7f
Type
Standard
Back to Health Canada Approvals